The investigators aim to perform a prospective study to evaluate the effectiveness of blind
corticosteroid injections to US-guided injections for the treatment of de Quervain's disease.
The results of the study will be used to validate current injection protocols or support the
incorporation of ultrasonography to treat the disease.